Intranasal delivery of FSD-C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis. Li Y-H, Yu J-Z, Liu C-Y, Zhang H, Zhang H-F, Yang W-F, Li J-L, Feng Q-J, Feng L, Zhang G-X, et al. Immunology. 2014 Apr 21. PMID: 24749492. Abstract CommentRecommendBookmarkWatch